Medical Affairs Intern, Genitourinary & Gynecological Oncology jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 17 hours ago

Medical Affairs Intern, Genitourinary & Gynecological Oncology

positionGaithersburg, Maryland, United States of America
timeInternship
remoteHybrid
seniorityIntern
money$37/hr - $41/hr
workcardStart in 2026 Spring

Alexion Pharmaceuticals, Inc. is seeking Junior and Master's students for a 12-week internship role in their Oncology Medical department. The intern will engage in KOL mapping, insight synthesis, and support congress planning for ongoing studies.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & BenefitsbadNo H1Bnote

Responsibilities

Discovery & KOL mapping, initial outreach and baseline insight interviews
Engage in deep insight synthesis, congress planning (speaker selection, draft agenda), and medical education concept co‑creation
Finalize congress & education deliverables, stakeholder review & approvals, measurement setup and project handover at end of assignment

Qualification

Oncology ExperienceProject ManagementMedical Affairs UnderstandingPublic SpeakingPresentation DesignCollaboration

Required

Junior and Master's students majoring in Biological Sciences, Pharmaceutical Sciences, or a related field
Candidates must have an expected graduation date after August 2026
Experience with project management with ability to deliver on time and on budget
Basic understanding of medical affairs and describing the impact of our activities for leadership updates
Ability to function collaboratively, including external partner management
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week

Preferred

Prior experience in the pharmaceutical industry is a plus
Experience in Oncology, TA preferred

Company

Alexion Pharmaceuticals, Inc.

twittertwittertwitter
Glassdoor3.9
company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
dateFounded in 1992
location
Boston, Massachusetts, USA
people-size1001-5000 employees
web-link
https://alexion.com

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin

Recent News

bloomberglaw.com
AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case
2025-12-20
Business Wire
Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com
2025-12-01
EuropaWire
AstraZeneca Secures FDA Approval for Koselugo to Treat Adults with NF1 Plexiform Neurofibromas Following Positive Phase III KOMET Results
2025-11-20
Company data provided by crunchbase